Device Trial Radar · NCT06616844
IDEAL: Efficacy of Porcine Placental Extracellular Matrix Augmented Plus Standard of Care (SOC) Versus SOC Alone for the Management of Diabetic Foot Ulcers
Last checked: Nov 20, 2026Latest source record: Oct 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
235
Planned (sponsor's estimate)
Start
Feb 12, 2025
Primary completion
Mar 2027
Study completion Sep 2027
Sponsor
- Lead sponsor
- ConvaTec Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 27, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A multi-center, prospective, observer-blinded, randomized controlled clinical trial to evaluate the efficacy of PPECM augmented standard of care versus standard of care alone in the management of hard-to-heal diabetic foot ulcers.
Conditions
- Wound Heal
- Ulcer
Interventions
InnovaMatrix® ACDevice
SOC plus weekly application of the study device
Primary outcomes
What the sponsor says the trial is designed to measure.
- To determine if PPECM augmented care is superior to SOC in the closure of diabetic foot ulcers at 12 weeks.Time frame: 12 weeks
Locations
21 sites in 1 country. Site status is shown where the registry gives one.
Limb Preservation Platform
Fresno, California
Angel City Research
Los Angeles, California
Clemente Clinical Research
Los Angeles, California
18 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.